BY no means an expert and as always, happy to be wrong........
A non inferior study generally takes a smaller sample that others.
Apparently it takes a smaller sample size to demonstrate that a product is similar (or no worse) than to prove it is different (better than).
Essentially, the sample size for the trial may be smaller ( and achieved sooner) than some us have been suggesting......
Hopefully the study protocol will be released soon......
Clinical trials, page-20
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.78 |
Change
0.780(8.67%) |
Mkt cap ! $206.7M | |||
| Open | High | Low | Value | Volume |
| $9.00 | $9.83 | $8.68 | $324.0K | 35.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 970 | $9.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.85 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |